Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | APP | P05067 | 6/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | MMP3 | P08254 | 1/20 | 0.33 |
| ▸ | MMP7 | P09237 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | MMP8 | P22894 | 1/20 | 0.33 |
| ▸ | MMP12 | P39900 | 1/20 | 0.33 |
| ▸ | MMP13 | P45452 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | PRKCI | P41743 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9625506 | 0.89 | KDM4E (0.48) | KDM4ELMNAAPPALDH1A1HPGD | |
| SCHEMBL10902501 | 0.87 | KDM4E (0.47) | KDM4ELMNAALDH1A1HPGD | |
| SCHEMBL11761929 | 0.86 | KDM4E (0.46) | KDM4ELMNAALDH1A1 | |
| SCHEMBL11759473 | 0.86 | KDM4E (0.46) | KDM4ELMNAALDH1A1 | |
| SCHEMBL11755938 | 0.86 | KDM4E (0.46) | KDM4ELMNAALDH1A1 | |
| SCHEMBL11760812 | 0.86 | KDM4E (0.46) | KDM4ELMNAALDH1A1 | |
| SCHEMBL10903156 | 0.86 | KDM4E (0.46) | KDM4ELMNAALDH1A1 | |
| E637 SCHEMBL1870685 | 0.84 | KDM4E (0.55) | KDM4ELMNAAPPMAPK1FTO | |
| E637 SCHEMBL41817 | 0.84 | KDM4E (0.55) | KDM4ELMNAAPPMAPK1FTO | |
| E637 SCHEMBL23309786 | 0.82 | KDM4E (0.53) | KDM4ELMNAAPPMAPK1FTO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250161182-A1 | ANTIMICROBIAL COMPOSITIONS | BIO-ACTIVES SYNERGIO LTD (IL) | 2025-05-22 | — | — | US | claimed |
| EP-4469037-A1 | ANTIMICROBIAL COMPOSITIONS | Bio-Actives Synergio Ltd (IL) | 2024-12-04 | — | — | EP | claimed |
| CN-118660702-A | Antimicrobial compositions | 生物活性协同有限公司 | 2024-09-17 | — | — | CN | claimed |
| WO-2023144808-A1 | ANTIMICROBIAL COMPOSITIONS | BIO-ACTIVES SYNERGIO LTD (IL) | 2023-08-03 | — | — | WO | claimed |
| EP-0473764-A1 | METAL COMPLEXES | Hider, Robert Charles (GB) | 1992-03-11 | — | — | EP | claimed |
| WO-1991014664-A1 | METAL COMPLEXES | HIDER ROBERT CHARLES (GB) | 1991-10-03 | — | — | WO | claimed |
| EP-0263138-B1 | IMPROVEMENTS IN OR RELATING TO THE TREATMENT OF SICKLE CELL DISEASE | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1991-06-12 | — | — | EP | claimed |
| US-4894455-A | Pharmaceutically active zinc complexes | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1990-01-16 | — | — | US | claimed |
| US-4866052-A | TREATING BLOOD WITH ZINC HYDROXY YRONE COMPLETE ENHANCES OXYGE N BINDING AFFINITY | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1989-09-12 | — | — | US | claimed |
| EP-0271529-A1 | PHARMACEUTICAL COMPOSITIONS | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1988-06-22 | — | — | EP | claimed |
| EP-0263138-A1 | IMPROVEMENTS IN OR RELATING TO THE TREATMENT OF SICKLE CELL DISEASE. | NAT RES DEV (GB) | 1988-04-13 | — | — | EP | claimed |
| WO-1987007893-A1 | PHARMACEUTICAL COMPOSITIONS | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1987-12-30 | — | — | WO | claimed |
| WO-1987005509-A1 | IMPROVEMENTS IN OR RELATING TO THE TREATMENT OF SICKLE CELL DISEASE | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1987-09-24 | — | — | WO | claimed |
| US-20250161182-A1 | ANTIMICROBIAL COMPOSITIONS | BIO-ACTIVES SYNERGIO LTD (IL) | 2025-05-22 | — | — | US | disclosed |
| EP-4469037-A1 | ANTIMICROBIAL COMPOSITIONS | Bio-Actives Synergio Ltd (IL) | 2024-12-04 | — | — | EP | disclosed |
| CN-118660702-A | Antimicrobial compositions | 生物活性协同有限公司 | 2024-09-17 | — | — | CN | disclosed |
| EP-0263138-A1 | IMPROVEMENTS IN OR RELATING TO THE TREATMENT OF SICKLE CELL DISEASE. | NAT RES DEV (GB) | 1988-04-13 | — | — | EP | disclosed |
| WO-1987007893-A1 | PHARMACEUTICAL COMPOSITIONS | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1987-12-30 | — | — | WO | disclosed |
| WO-1987005509-A1 | IMPROVEMENTS IN OR RELATING TO THE TREATMENT OF SICKLE CELL DISEASE | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1987-09-24 | — | — | WO | disclosed |
| US-4059595-A | Process for preparing 3-oxy-4H-pyran-4-one derivatives | OTSUKA KAGAKU YAKUHIN KABUSHIKI KAISHI (JA) | 1977-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250161182-A1 | ANTIMICROBIAL COMPOSITIONS | NOD2, PYCARD, CLPP | KDM4E 4332/4885LMNA 2204/4885APP 2790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.